We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.
Our Education Programs
The bioscience and medical industries and academic research programs need intelligent, engaged, well-trained talent to fill jobs in the rapidly expanding field of regenerative medicine. The Stem Cell Institute prepares students who are ready to meet this need and who are eager to move the next generation of research forward. Learn more about our graduate programs:
In the News
An experimental stem cell treatment proved effective at halting this disease with no serious side effects up to a year later, a study published Wednesday in the New England Journal of Medicine found. It is the first treatment using personalized, genetically identical cells derived from the patient. However, serious concerns about such research persist. Three women with macular degeneration were blinded in 2015 after undergoing stem cell treatment in Florida. The patients experienced a variety of complications and are now blind, according to a paper published Thursday in The New England Journal of Medicine.
When scientists can determine what type of cell a stem cell will become, they can better manipulate cells for stem cell therapy. Scientists at Rutgers and other universities have created a new way to identify the state and fate of stem cells earlier than previously possible. The approach, called EDICTS (Epi-mark Descriptor Imaging of Cell Transitional States), involves labeling epigenetic modifications and then imaging the cells with super resolution to see the precise location of the marks.
The regenerative biology team at the Morgridge Institute for Research, led by stem cell pioneer and University of Wisconsin-Madison Professor James Thomson, is studying whether stem cell differentiation rates can be accelerated in the lab and made available to patients faster. While the study published in the February issue ofScience Direct suggests that cellular timing is a stubborn process, the Thomson lab is exploring a variety of follow-up studies on potential factors that could help cells alter their pace, Barry says.
The research team of Dr. Scott Kaufmann, leader of Mayo’s Anticancer Drug Action Laboratory, and Daniel Harki, a U of M assistant professor of medicinal chemistry, Stem Cell Institute member, and director of the Harki Lab, in January saw their patent application for a method of “assessing enzyme-nucleic acid complexes” published by the U.S. Patent and Trademark Office, with Mayo and the U of M named as the assignees.
Weekly Research Conference
Wednesday, March 22, 2017 - 4:00pm
Cellular Interactions Underlying Vertebrate Embryogenesis and Cardiac Development
Miguel Torres, PhD
Centro Nacional de Investigaciones Cardiovasculares (CNIC)